Synuclein-One (Syn-One) Study

Christopher H. Gibbons, MD, FAAN presented an abstract and poster at the American Academy of Neurology Annual Meeting in April, 2023 with research findings of the efficacy of CND Life Sciences Syn-One skin biopsy test. This Neurology Live article from the meeting reported overall sensitivity among four diagnoses at 95.5% with 92.7% sensitivity with Parkinson’s. Visit the Syn-One Test page for additional information.

Have an article you would like added or a category you would like to see, please send us an email.